News

Keep up to date with CTx announcements, press releases and general news items

By CTxadmin
 • 
10 months ago

This unique free full-day symposium, a collaboration between Cancer Therapeutics CRC (CTx), Merck Sharp & Dohme (MSD), and the Victorian Comprehensive Cancer Centre (VCCC), brings together leading industry, academic and clinical experts to discuss opportunities to progress biological discoveries to effective therapies, covering cancer drug discovery, …
Read More

By CTxadmin
 • 
11 months ago

In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies.
Published today in the journal Nature, the research reveals the first class …
Read More

By CTxadmin
 • 
1 year ago

Cancer Therapeutics CRC (CTX), a small molecule oncology drug discovery and development group partnered with some of Australia’s pre-eminent medical research institutions, is pleased to announce two Focal Adhesion Kinase (FAK) targeting drug candidates originally developed by CTX have been acquired by Innate Immunotherapeutics Ltd …
Read More

By CTxadmin
 • 
1 year ago

CEOHandover07a

Brett will succeed Dr Warwick Tong who has led CTX for the past 6 years and who will continue to provide services to the organisation in an advisory capacity. …
Read More

By CTxadmin
 • 
2 years ago

Cancer Therapeutics CRC (CTx) is offering a number of scholarships to currently enrolled Honours students for the 2018 Lorne Cancer Conference. For more information download this pdf.
Interested students should contact education@cancercrc.com to obtain an application form.

Closing date: …
Read More

By CTxadmin
 • 
2 years ago

Congratulations to CTx Participants CSIRO and Clinical Genomics – members of the Colvera team that won the 2017 Johnson & Johnson Eureka prize for Innovation in Medical Research. 

Colvera is a clinically validated blood test that …
Read More